当前位置:首页 - 行情中心 - 太龙药业(600222) - 财务分析 - 现金流量表

太龙药业

(600222)

  

流通市值:29.42亿  总市值:30.19亿
流通股本:5.59亿   总股本:5.74亿

现金流量表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金2,087,287,574.31,514,219,938.381,008,483,916.84490,861,271.25
收到的税费返还40,699.54---
收到其他与经营活动有关的现金46,574,461.9422,730,287.297,943,894.914,940,065.95
经营活动现金流入的平衡项目0000
经营活动现金流入小计2,133,902,735.781,536,950,225.671,016,427,811.75495,801,337.2
购买商品、接受劳务支付的现金1,368,699,084.411,026,047,626.1689,379,842.18346,432,947.77
支付给职工以及为职工支付的现金380,601,855.22287,825,752.54203,461,165.56107,903,005.13
支付的各项税费84,436,221.9463,116,402.953,691,490.7325,471,693.56
支付其他与经营活动有关的现金256,427,998.81212,650,167.15157,897,137.28108,262,031.3
经营活动现金流出的平衡项目0000
经营活动现金流出小计2,090,165,160.381,589,639,948.691,104,429,635.75588,069,677.76
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额43,737,575.4-52,689,723.02-88,001,824-92,268,340.56
二、投资活动产生的现金流量:
收回投资收到的现金533,407,418.01376,506,202.74124,331,201.5451,077,521.1
取得投资收益收到的现金55,100,231.3254,764,166.2425,099,154.4511,518,986.68
处置固定资产、无形资产和其他长期资产收回的现金净额218,310.6252,285.6130,840130,410
处置子公司及其他营业单位收到的现金净额1,800,000950,000500,000200,000
投资活动现金流入的平衡项目0000
投资活动现金流入小计590,525,959.93432,472,654.58150,061,195.9962,926,917.78
购建固定资产、无形资产和其他长期资产支付的现金43,133,235.2529,580,253.7417,994,895.739,895,727.97
投资支付的现金697,412,085439,463,680190,980,00072,670,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计740,545,320.25469,043,933.74208,974,895.7382,565,727.97
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-150,019,360.32-36,571,279.16-58,913,699.74-19,638,810.19
三、筹资活动产生的现金流量:
取得借款收到的现金668,366,098.15240,154,134.92192,600,000120,100,000
收到其他与筹资活动有关的现金441,810,653.97281,348,090.83207,103,900.8339,619,213.09
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,110,176,752.12521,502,225.75399,703,900.83159,719,213.09
偿还债务支付的现金600,500,000251,900,000144,400,00063,400,000
分配股利、利润或偿付利息支付的现金50,168,533.4232,684,204.4821,311,769.9121,255,830.49
支付其他与筹资活动有关的现金432,944,201.33256,064,782.75200,879,741.9326,077,903.13
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,083,612,734.75540,648,987.23366,591,511.84110,733,733.62
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额26,564,017.37-19,146,761.4833,112,388.9948,985,479.47
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-79,717,767.55-108,407,763.66-113,803,134.75-62,921,671.28
加:期初现金及现金等价物余额254,721,283.24254,721,283.24254,721,283.24254,721,283.24
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额175,003,515.69146,313,519.58140,918,148.49191,799,611.96
补充资料:
净利润44,829,287.68--42,839,914.1-
资产减值准备2,462,115.49-4,414,940-
固定资产和投资性房地产折旧46,262,029.57-22,834,344.29-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧46,262,029.57-22,834,344.29-
无形资产摊销5,024,095.7-2,414,965.65-
长期待摊费用摊销7,766,026.32-3,845,733.22-
处置固定资产、无形资产和其他长期资产的损失-615,485.96--577,412.44-
固定资产报废损失79,829.62-260.06-
公允价值变动损失534,035.44-819,339.39-
财务费用54,905,880.44-26,315,187.4-
投资损失5,889,831.01-2,487,060.68-
递延所得税-6,756,176.96--7,287,320.08-
其中:递延所得税资产减少-5,744,496.1--7,141,028.42-
递延所得税负债增加-1,011,680.86--146,291.66-
存货的减少-7,384,026.61--7,941,790.42-
经营性应收项目的减少-3,067,318.37-33,856,028.38-
经营性应付项目的增加-123,271,189.42--138,401,169.16-
现金的期末余额175,003,515.69-140,918,148.49-
减:现金的期初余额254,721,283.24-254,721,283.24-
公告日期2024-03-282023-10-272023-08-192023-04-29
审计意见(境内)标准无保留意见
TOP↑